2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults - PubMed
10 hours ago
- #COVID-19
- #clinical guideline
- #antiviral treatment
- The Infectious Diseases Society of America released a 2025 clinical practice guideline update on antiviral treatment for adults with mild to moderate COVID-19.
- The update includes 9 revised recommendations focusing on the use of nirmatrelvir/ritonavir, remdesivir, and molnupiravir.
- Recommendations are based on a systematic literature review and adhere to the GRADE methodology for evidence certainty and recommendation strength.
- The guideline provides an algorithm to assist in selecting appropriate antiviral treatments.
- Potential conflicts of interest among panelists are disclosed, with management strategies in place to mitigate bias.